MSU Research Foundation and LEAP Announce Teams for Second Cohort of Lansing Regional SBIR + MedTech Accelerator
East Lansing, Mich. –– The Michigan State University Research Foundation (MSU Research Foundation) and the Lansing Economic Area Partnership (LEAP) are pleased to announce the teams selected for the second cohort of the Lansing Regional SBIR + MedTech Accelerator program. The program is a joint initiative which aims to help early-stage medical technology companies accelerate their growth and success. Teams participate in an 18-week program to help build new medical technology startup companies. The program includes support and guidance in areas such as customer discovery, market analysis, intellectual property management, financing, business plan creation, and more. The program also assists in applying for local pre-SBIR grants such as the Business Accelerator Fund, the Emerging Technologies Fund, NSF Regional I-Corp, Michigan Translation Research and Commercialization (MTRAC) grant, ADVANCE grant, NSF Partnership for Innovation (PFI), and others.
"We have an outstanding cohort of companies representing a wide variety of technologies," said Jeff Wesley, Executive Director of Spartan Innovations, a subsidiary of the MSU Research Foundation. "We're confident they'll make significant contributions to the medtech industry."
The 2023 cohort teams include:
Translational Osteosynthesis, which provides cutting-edge instruments, devices, technologies, and services for surgeons and scientists aiming to optimize bone healing and regeneration.
Smart Bridge Medical, Inc., which is developing their next-generation patented POPSafe™ Tracheostomy Tube and POPSafe™ Endotracheal Tube respiratory medical devices that solve dangerous accidental ventilator disconnects.
UV-C SAFE, INC Germicidal, which is making person-to-person business transactions safer by disinfecting objects and the surrounding air with Human-Safe Ultraviolet Light.
Total Reentry Solution (TRS), a digital healthcare tool that helps formerly incarcerated individuals by providing accurate and comprehensive care plans, facilitating successful reintegration into society.
AerBots, which is improving medicine delivery with patented drone technology.
Great Lakes Biologics, a Contract Manufacturing Organization (CMO) specializing in the process development of small-scale batches of biologic actively product candidates used in pharmaceutical research and development under service contracts.
BeAware, a mobile app designed to improve safety and communication for the deaf and hard of hearing by developing real-time speech diarization, the process of partitioning audio streams to identify sources of sound.
DM Reads, which is developing Smarter™ Safety utilizing DRAFT™ patented platform technology focused on human factors and ergonomics which can be measured through evidence-based solutions with the potential of better outcomes in respiratory health.
Tirum Diagnostics, Inc., which is working to diagnose cancer metastasis at the time of biopsy, prior to any PET/CT scan imaging using cancer genomics and machine learning.
The Lansing SBIR + MedTech Accelerator is part of LEAP's $1.1M plan to expand the Lansing Region's Life Sciences and MedTech industry cluster. The plan includes $813,000 from a U.S. Economic Development Administration (EDA) CARES Act Recovery Assistance grant LEAP received in 2021.
"LEAP is excited to partner with MSU Research Foundation on the second cohort of the successful SBIR + Medtech program,” said Bob Trezise, President and CEO of LEAP. “This program is a vital component of our larger regional efforts to bring innovative ideas to market and advance health care in our community and beyond."
The SBIR+ MedTech Accelerator runs virtually from April 17th to August 20th. Business lectures are open to the public. For more information about the program, visit msufoundation.org/lansing-regional-sbir-medtech-accelerator